Jane Street Group, LLC Madrigal Pharmaceuticals, Inc. Transaction History

Jane Street Group, LLC

$88.2 Billion
Q2 2024

A detailed history of Jane Street Group, LLC transactions in Madrigal Pharmaceuticals, Inc. stock. As of the latest transaction made, Jane Street Group, LLC holds 36,204 shares of MDGL stock, worth $8.44 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

36,204

Previous 25,151 43.95%

Holding current value

$8.44 Million

Previous $6.72 Million 51.01%

% of portfolio

0.01%

Previous 0.01%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$193.33 - $291.99 $2.14 Million - $3.23 Million	11,053 Added 43.95%	36,204 $10.1 Million
Q1 2024 May 15, 2024	SELL	$171.37 - $283.23 $32.8 Million - $54.3 Million	-191,667 Reduced 88.4%	25,151 $6.72 Million
Q4 2023 Feb 14, 2024	BUY	$120.4 - $237.13 $13.7 Million - $26.9 Million	113,432 Added 109.72%	216,818 $50.2 Million
Q3 2023 Nov 14, 2023	BUY	$146.04 - $225.78 $9.22 Million - $14.3 Million	63,163 Added 157.03%	103,386 $15.1 Million
Q2 2023 Aug 14, 2023	SELL	$203.88 - $312.0 $15.3 Million - $23.4 Million	-74,969 Reduced 65.08%	40,223 $9.29 Million
Q1 2023 May 15, 2023	BUY	$231.06 - $307.08 $16.4 Million - $21.8 Million	71,112 Added 161.32%	115,192 $27.9 Million
Q4 2022 Feb 14, 2023	BUY	$58.39 - $296.54 $2.57 Million - $13.1 Million	44,080 New	44,080 $12.8 Million
Q2 2022 Aug 16, 2022	BUY	$58.04 - $100.2 $28,845 - $49,799	497 Added 1.85%	27,392 $1.96 Million
Q1 2022 May 17, 2022	SELL	$55.89 - $101.89 $511,114 - $931,784	-9,145 Reduced 25.37%	26,895 $2.64 Million
Q4 2021 Feb 15, 2022	BUY	$72.34 - $95.09 $1.78 Million - $2.34 Million	24,613 Added 215.39%	36,040 $3.05 Million
Q2 2021 Aug 16, 2021	BUY	$97.2 - $137.59 $11,566 - $16,373	119 Added 1.05%	11,427 $1.11 Million
Q1 2021 May 18, 2021	BUY	$108.54 - $125.2 $356,336 - $411,031	3,283 Added 40.91%	11,308 $1.32 Million
Q4 2020 Feb 17, 2021	SELL	$110.06 - $133.7 $202,290 - $245,740	-1,838 Reduced 18.64%	8,025 $892,000
Q3 2020 Nov 17, 2020	SELL	$99.78 - $124.21 $3.73 Million - $4.64 Million	-37,380 Reduced 79.12%	9,863 $1.17 Million
Q2 2020 Aug 17, 2020	BUY	$60.13 - $125.71 $2.62 Million - $5.47 Million	43,546 Added 1177.87%	47,243 $5.35 Million
Q3 2019 Nov 14, 2019	BUY	$84.4 - $106.53 $99,085 - $125,066	1,174 Added 46.53%	3,697 $319,000
Q2 2019 Aug 15, 2019	BUY	$91.13 - $142.5 $16,676 - $26,077	183 Added 7.82%	2,523 $265,000
Q1 2019 May 16, 2019	BUY	$103.48 - $143.84 $35,907 - $49,912	347 Added 17.41%	2,340 $293,000
Q4 2018 Feb 15, 2019	SELL	$94.77 - $215.54 $47,195 - $107,338	-498 Reduced 19.99%	1,993 $225,000
Q3 2018 Nov 14, 2018	BUY	$207.3 - $300.31 $132,464 - $191,898	639 Added 34.5%	2,491 $533,000
Q2 2018 Aug 15, 2018	BUY	$101.55 - $313.9 $188,070 - $581,342	1,852 New	1,852 $518,000

Others Institutions Holding MDGL

# of Institutions

297

Shares Held

22M

Call Options Held

757K

Put Options Held

370K

View Full List

About MADRIGAL PHARMACEUTICALS, INC.

Ticker MDGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 17,103,400
Market Cap $3.99B
Description
Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...

More about MDGL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Account

Jane Street Group, LLC Madrigal Pharmaceuticals, Inc. Transaction History